HomeInvestors HealthScinai Immunotherapeutics regains compliance with Nasdaq listing rule

Scinai Immunotherapeutics regains compliance with Nasdaq listing rule

525-5250815_gold-ball-free-png-gold-ball-png-clipart

August 29, 2024

Scinai Immunotherapeutics regains compliance with Nasdaq listing rule

Source link

Previous article

Why Stratasys Stock Sank 15% Today

Next article

Why Nutanix Stock Was Surging Today

Investors Health Image

latest articles

explore more

LEAVE A REPLY Cancel reply

Please enter your comment!

Please enter your name here

You have entered an incorrect email address!

Please enter your email address here